FDA makes a decision on the fate of Avandia, restricting access to the drug
The United States FDA (the federal Food and Drug Administration) has announced that it will significantly restrict access to the diabetes drug Avandia for new patients. [1] The pharmaceutical...
View ArticleRECALL OF OCTAGAM IGIV (Immune Globulin Intravenous) USED IN IMMUNODEFICIENCY...
On August 20, 2010, Octapharma USA Inc. recalled ALL lots of OCTAGAM (Immune Globulin Intravenous (human) 5% Liquid Preparation) currently in the United States. This voluntary market withdrawal was...
View ArticleActavis (Fentanyl) Transdermal Pain Patch Recall Due to Dangerous Defects
On October 21, 2010, the FDA notified healthcare professionals, directing a recall after laboratory testing identified an Actavis fentanyl patch that released its active ingredient faster than the...
View ArticleBenicar/Olmesartan Drug Warning
The law firm of Pearson, Randall & Schumacher, P.A. is currently investigating the serious side effects of Olmesartan (sold under the names of Benicar, Benicar HCT, Tribenzor, or Azor). These...
View ArticleContaminated Cubicin® May Cause Serious or Deadly Injury
According to its website, “Cubist Pharmaceuticals, Inc. is a bio-pharmaceutical company focused on the research, commercialization and creation of pharmaceutical products that address unmet medical...
View Article
